Trial Profile
A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2021
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 10 Mar 2021 Results assessing pharmacokinetics, safety and acceptability of two 3-month dapivirine (DPV) VRs compared with the monthly DPV VR, presented at the 28th Conference on Retroviruses and Opportunistic Infections.
- 25 Jan 2019 Status changed from active, no longer recruiting to completed.
- 24 Oct 2018 Planned End Date changed from 1 Oct 2018 to 1 Jan 2019.